We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBER ISSUES NEW PLAN TO DEAL WITH COUNTERFEIT PRODUCT REPORTS
CBER ISSUES NEW PLAN TO DEAL WITH COUNTERFEIT PRODUCT REPORTS
March 19, 2004
The Center for Biologics Evaluation and Research (CBER) has released details about the action plan it will implement when responding to reports of counterfeit drugs.